NCT04560712

Brief Summary

This trial investigates how well acupuncture works for the management of pain after surgery in patients having open colorectal or pancreatic surgery. Acupuncture may help to reduce postoperative symptoms including pain. This study may help researchers learn if acupuncture reduces after-surgery side effects and improves recovery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Aug 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Aug 2020Dec 2027

First Submitted

Initial submission to the registry

July 27, 2020

Completed
16 days until next milestone

Study Start

First participant enrolled

August 12, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 23, 2020

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

7.4 years

First QC Date

July 27, 2020

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Adherence rate to daily acupuncture

    Acupuncturist will document in the medical record all the treatments participants are completing and also document if missing any treatments.

    Up to 7 days

  • Compliance

    Acupuncturist and research coordinator will document in EPIC if participant is compliant with acupuncture sessions (study intervention) and with study questionnaires.

    Up to 7 days

  • Retention

    Will be measured as percentage of patients who complete the study out of the number of patients after study randomization.

    Up to 7 days

Secondary Outcomes (3)

  • Postoperative opioid use for pain management

    24 hours

  • Pain levels

    Up to 7 days

  • Satisfaction of pain control

    Up to 7 days

Other Outcomes (2)

  • Dietary recovery

    Up to 7 days

  • Postoperative length of stay

    Up to 7 days

Study Arms (2)

Arm I (acupuncture, usual care)

EXPERIMENTAL

Beginning the day after surgery, patients undergo acupuncture sessions over 25 minutes QD for up to 7 days. Patients also undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits.

Procedure: Acupuncture TherapyOther: Best PracticeOther: Questionnaire Administration

Arm II (usual care)

ACTIVE COMPARATOR

Patients undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits.

Other: Best PracticeOther: Questionnaire Administration

Interventions

Undergo acupuncture

Also known as: Acupuncture
Arm I (acupuncture, usual care)

Undergo usual care

Also known as: standard of care, standard therapy
Arm I (acupuncture, usual care)Arm II (usual care)

Ancillary studies

Arm I (acupuncture, usual care)Arm II (usual care)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing open gastrointestinal cancer resection (pancreatic or colorectal)
  • Must understand and read English
  • Sign a written informed consent and willing to follow protocol requirements
  • Able to consent to treatment

You may not qualify if:

  • Chronic opioid use \> 90 mg MME (morphine milligram equivalents) for more than 7 days
  • Mechanical bowel obstruction
  • Active seizure activity after admission
  • Compromised cognitive function per referring physician and/or inability to cooperate with acupuncture procedure
  • Direct admission to intensive care unit after operation will result in removal from protocol
  • Prior intra-abdominal operation in the past 6 months
  • Any contraindications to acupuncture including infections or inability to access acupoint sites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Interventions

Acupuncture TherapyPractice Guidelines as TopicStandard of Care

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsGuidelines as TopicQuality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationQuality Indicators, Health Care

Study Officials

  • Lorenzo Cohen

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2020

First Posted

September 23, 2020

Study Start

August 12, 2020

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations